Deal aims to cut debt and strengthen balance sheet Company refocuses on GLP-1 drugs after reporting annual loss South African drugmaker Aspen Pharmacare said on Monday it would sell most of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results